Skip to main content
Log in

Polymorphism in the Tumor Necrosis Factor-α Gene in Women with Preeclampsia

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose : We determined whether genetic variability in the gene encoding for tumor necrosis factor-α (TNF-α) contributes to individual differences in susceptibility to the development of preeclampsia.

Methods : The study involved 133 preeclamptic and 115 healthy control pregnant women who were genotyped for C-850T polymorphism in the TNF-α gene promoter. Chi-square analysis was used to assess genotype and allele frequency differences between preeclamptic women and controls.

Results : A significantly different genotype distribution of C-850T polymorphism was observed between the two groups, with the frequency of the variant T allele being significantly reduced in the preeclamptic group (4.5%) when compared with the control group (9.6%) (P = 0.03; OR = 0.45, 95% CI = 0.22–0.92). Accordingly, the odds ratio for preeclampsia associated with the pooled TT and CT genotypes was 0.367 (P = 0.02; 95% CI = 0.159–0.847).

Conclusions : The T allele of the TNF-α gene may modify individual preeclampsia risk, being protective against the development of the complication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Arngrimsson R, Bjö rnsson H, Geirsson R: Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertens Pregn 1995;14:27–38

    Google Scholar 

  2. Cincotta RB, Brennecke SP: Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet 1998;60:23–27

    Google Scholar 

  3. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, Catalano PM: The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998;179:1032–1037

    Google Scholar 

  4. Jonsdottir L, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N: Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995;74: 772–776

    Google Scholar 

  5. Wilton AN, Cooper DW, Brennecke SP, Bishop SM, Marshall P: Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DR beta. Lancet 1990;336:653–657

    Google Scholar 

  6. Humphrey KE, Harrison GA, Cooper DW, Wilton AN, Brennecke SP, Trudinger BJ: HLA-G deletion polymorphism and pre-eclampsia/eclampsia. Br J Obstet Gynaecol 1995;102:707–710

    Google Scholar 

  7. Chen G, Wilson R, Boyd P, Mckillop JH, Leitch C, Walker JJ, Burdon RH: Normal superoxide dismutase (SOD) gene in pregnancy-induced hypertension: Is the decreased SOD activity a secondary phenomenon? Free Radic Res 1994;21:59–66

    Google Scholar 

  8. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel J-M: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59–61

    Google Scholar 

  9. Dizon-Townson DS, Nelson LM, Easton K, Ward K: The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902–905

    Google Scholar 

  10. Zusterzeel PL, Peters WH, Visser W, Hermsen KJ, Roelofs HM, Steegers EA: A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia. J Med Genet 2001;38:234–237

    Google Scholar 

  11. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T: Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997;34:525–526

    Google Scholar 

  12. Arngrimsson R, Sigurardottir S, Frigge ML, Bjarnadottir RI, Jonsson T, Stefansson H, Baldursdottir A, Einarsdottir AS, Palsson B, Snorradottir S, Lachmeijer AM, Nicolae D, Kong A, Bragason BT, Gulcher JR, Geirsson RT, Stefansson K: A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999;8:1799–1805

    Google Scholar 

  13. Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW, Brennecke SP: A genome scan in families fromAustralia andNewZealand confirms the presence of a maternal susceptibility locus for preeclampsia, on chromosome 2. Am J Hum Genet 2000;67:1581– 1585

    Google Scholar 

  14. Harrison GA, Humphrey KE, Jones N, Badenhop R, Guo G, Elakis G, Kaye JA, Turner RJ, Grehan M, Wilton AN, Brennecke SP, Cooper DW: A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 1997;60:1158–1167

    Google Scholar 

  15. Arngrimsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA, Bjarnadottir RI, Brock DJ, Geirsson RT, Connor JM, Soubrier F: Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 1997;61:354–362

    Google Scholar 

  16. Lewis I, Lachmeijer G, Downing S, Dekker G, Glazebrook C, Clayton D, Morris NH, O'Shaughnessy KM: Failure to detect linkage of preeclampsia to the region of the NOS3 locus on chromosome 7q. Am J Hum Genet 1999;64:310–313

    Google Scholar 

  17. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, nnett WA: Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1 beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999;181:915–920

    Google Scholar 

  18. Livingston JC, Park V, Barton JR, Elfering S, Haddad B, Mabie WC, Quasney M, Sibai BM: Lack of association of severe preeclampsia with maternal and fetal mutantalleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasmatumor necrosis factor alpha levels. Am J Obstet Gynecol 2001;184:1273–1277

    Google Scholar 

  19. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP: Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505– 2512

    Google Scholar 

  20. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH: Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression inpre-eclampsia. Clin Exp Immunol 1996;104:154–159

    Google Scholar 

  21. Lachmeijer AM, Crusius JB, Pals G, Dekker GA, Arngrimsson R, ten Kate LP: Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia. Obstet Gynecol 2001;98:612–619

    Google Scholar 

  22. Kilpatrick DC: HLA-dependent TNF secretory response may provide an immunogenetic link between pre-eclampsia and type 1 diabetes mellitus. Dis Markers 1996;13:43–47

    Google Scholar 

  23. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B: Macrophage-induced apoptosis limits endovascular trophoblast invasion in theuterine wall of preeclamptic women. Lab Invest 2001;81:1143–1152

    Google Scholar 

  24. Peltonen L, Jalanko A, Varilo T: Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999;8:1913– 1923

    Google Scholar 

  25. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–S22

    Google Scholar 

  26. Kato T, Honda M, Kuwata S, Juji T, Kunugi H, Nanko S, Fukuda M, Honda Y: Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy. Am J Med Genet 1999;88:301–304

    Google Scholar 

  27. Chesley L, Annitto L, Cosgrave R: The familial factor in toxemia of pregnancy. Obstet Gynecol 1968;32:303–311

    Google Scholar 

  28. Meydani SN, Dinarello CA: Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 1993;8:65–72

    Google Scholar 

  29. Williams MA, Zingheim RW, King IB, Zebelman AM: Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995;6:232–237

    Google Scholar 

  30. Ruuls SR, Sedgwick JD: Unlinking tumor necrosis factor biology from the major histocompatibility complex: Lessons from human genetics and animal models. Am J Hum Genet 1999;65:294–301

    Google Scholar 

  31. Dizon-Townson DS, Major H, Ward K: A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia. J Reprod Immunol 1998;38:55–61

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seppo Heinonen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heiskanen, J., Romppanen, EL., Hiltunen, M. et al. Polymorphism in the Tumor Necrosis Factor-α Gene in Women with Preeclampsia. J Assist Reprod Genet 19, 220–223 (2002). https://doi.org/10.1023/A:1015306818507

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015306818507

Navigation